10 Reasons We Like DaVita Dialysis as the Tenant of our DST 1031 Exchange Investments

  1. DaVita is a Fortune 500® company publicly traded on the NYSE as DVA3
  2. DaVita Kidney Care is a leading provider of kidney care in the United States, with clinical outcomes that were the best or among the best in the United States in almost every category in 20171
  3. DaVita has a market capitalization of 12.8 billion dollars as of August 6, 20184
  4. DaVita has 70,800 full time employees2
  5. DaVita had annual revenue of 11.11 billion dollars in 20174
  6. DaVita VillageHealth program continues to grow its commercial and government operations with more than 10 health plan and health system partnerships, 8 Medicare Advantage Special Needs Plans and 3 ESRD Seamless Care Organizations (ESCOs)1
  7. DaVita achieved savings of $75 million during the first performance year of their pilot program with ESCOs1
  8. As of June 30, 2017, DaVita Kidney Care provided dialysis services to a total of approximately 214,700 patients at 2,662 outpatient dialysis centers, of which 2,445 centers were located in the United States and 217 centers were located in 11 countries outside of the United States.3
  9. DaVita’s leadership development initiatives and social responsibility efforts have been recognized by Fortune Magazine, Modern Healthcare, Newsweek, and World Blu2
  10. Legendary investor Warren Buffett’s Berkshire Hathaway Inc reported a 22.1% stake in DaVita as of May 3, 20185

About Kay Properties and www.kpi1031.com 

Kay Properties is a national Delaware Statutory Trust (DST) investment firm. The www.kpi1031.com platform provides access to the marketplace of DSTs from over 25 different sponsor companies, custom DSTs only available to Kay clients, independent advice on DST sponsor companies, full due diligence and vetting on each DST (typically 20-40 DSTs) and a DST secondary market.  Kay Properties team members collectively have over 115 years of real estate experience, are licensed in all 50 states, and have participated in over 15 Billion of DST 1031 investments.

This material does not constitute an offer to sell nor a solicitation of an offer to buy any security. Such offers can be made only by the confidential Private Placement Memorandum (the “Memorandum”). Please read the entire Memorandum paying special attention to the risk section prior investing.  IRC Section 1031, IRC Section 1033 and IRC Section 721 are complex tax codes therefore you should consult your tax or legal professional for details regarding your situation.  There are material risks associated with investing in real estate securities including illiquidity, vacancies, general market conditions and competition, lack of operating history, interest rate risks, general risks of owning/operating commercial and multifamily properties, financing risks, potential adverse tax consequences, general economic risks, development risks and long hold periods. There is a risk of loss of the entire investment principal. Past performance is not a guarantee of future results. Potential cash flow, potential returns and potential appreciation are not guaranteed.

Nothing contained on this website constitutes tax, legal, insurance or investment advice, nor does it constitute a solicitation or an offer to buy or sell any security or other financial instrument. If you are not the intended recipient of this message, any use, dissemination, distribution or copying of this communication is strictly prohibited. If you have received this communication in error, please immediately notify the sender and permanently delete all copies that you may have. Securities offered through Growth Capital Services, member FINRASIPC, Office of Supervisory Jurisdiction located at 582 Market Street, Suite 300, San Francisco, CA 94104.

Email this to someoneTweet about this on TwitterShare on FacebookShare on LinkedIn